Status:

COMPLETED

Improving Quality of Life Using Patient Reported Outcomes Measures Post-operative Via Text Messaging

Lead Sponsor:

University of Michigan Rogel Cancer Center

Conditions:

Gynecologic Cancer

Eligibility:

FEMALE

18+ years

Phase:

NA

Brief Summary

This study is investigating a new way to monitor patients who are recovering at home after surgery. This study uses text messages to ask patients to review their own symptoms and then reply with the l...

Eligibility Criteria

Inclusion

  • Age 18 years of age or greater.
  • Planning to undergo a surgical procedure via a laparotomy incision for a suspected or known gynecologic malignancy. There is no restriction on the spectrum of pathology or disease.
  • The ability and willingness to send and receive short messaging service (SMS) text messages.
  • Able to read and understand English.
  • Willing and able to provide informed consent

Exclusion

  • Persons who are planning to undergo a minimally invasive procedure without laparotomy.
  • Persons unable to be contacted by SMS text message or choose to opt-out of the study.
  • Patients who do not have access to the internet via a home computer or a smart phone.

Key Trial Info

Start Date :

January 5 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 2 2023

Estimated Enrollment :

102 Patients enrolled

Trial Details

Trial ID

NCT04852471

Start Date

January 5 2022

End Date

May 2 2023

Last Update

October 11 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Michigan Rogel Cancer Center

Ann Arbor, Michigan, United States, 48109